From: The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
Drugs or molecules | Effects | References |
---|---|---|
Quercetin | Reduce lipid accumulation and senescence phenotype | [165] |
Metformin | Inhibiting the inflammation, oxidative stress, foam cell formation and apoptosis of macrophages | [166] |
GCV | decreased expression of MMPs linked to plaque destabilization | [17] |
Statins | Accelerating DNA damage repair; suppressing oxidative stress | |
Bradykinin | Protects ECs from superoxide-induced senescence | [168] |
Fisetin | Regulating lipid metabolism; anti-aging; anti-oxidation; anti-inflammatory | [169] |
ABT-263 | Eliminate senescent cells | [17] |
Dasatinib + quercetin (D + Q) | Reduces the number of senescent VSMCs; reduced aortic calcification | [170] |
Resveratrol | Prevent ROS-induced senescence in vascular cells | [114] |
Nicotinamide mononucleotide | Reduce the NAD depletion; reduce vascular aging | [171] |
Ethanol | Resisting endothelial senescence and the SASP inflammatory factor secretion | [172] |
Sirtuin 6 | Preserved telomere integrity; delayed cellular senescence; reduced inflammatory cytokine expression | [173] |
TRF2 | Regulate VSMCs senescence; increased the fibrous cap area; reduced core size | [174] |
Pin1 | rescued cellular senescence in atherosclerotic VSMCs | [175] |